DEVELOPMENT OF A BABOON MODEL OF LIVER CANCER
狒狒肝癌模型的研制
基本信息
- 批准号:8357717
- 负责人:
- 金额:$ 3.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-05-01 至 2012-04-30
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAutologousCancer EtiologyCell TransplantsCellsCessation of lifeDevelopmentDiagnosisDiagnosticFundingGene Transduction AgentGene-ModifiedGenesGeneticGrantHepatocyteImaging TechniquesLentivirus VectorLiverMalignant NeoplasmsMalignant neoplasm of liverMethodsModelingModificationNational Center for Research ResourcesOncogenesPapioPrimatesPrincipal InvestigatorPropertyResearchResearch InfrastructureResourcesSCID MiceSourceStagingSystemUnited States National Institutes of Healthanticancer researchcancer therapycostgene cloningmouse modelnew technologyprogramstumortumorigenic
项目摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
This is a pilot program to create a new model for liver cancer research and therapy. We will create a baboon model of liver cancer for use in new technologies involving advanced diagnostics and therapies using sophisticated imaging techniques to visualize and treat the tumor. Currently no large animal model of liver cancer is available to develop and perfect these methods. Liver cancer is the 4th leading cause of cancer death worldwide. Because it is a fast-growing tumor that is rarely diagnosed in the early stages, liver cancer is typically fatal within a year of diagnosis. In this program we will clone the genes involved in liver cancer from the baboon, such that all genes involved are homologous to the host. We will introduce genetic modifications to convert the genes into cancer inducing genes or oncogenes. We will use gene therapy vectors (Lentivirus vectors) to introduce multiple modified genes into liver cells (hepatocytes) growing in our well established hepatocyte culture system for baboon hepatocytes. Cells with tumorigenic properties will first be selected in the SCID mouse model and then introduced into the liver of baboon that was the original donor of the cells (autologous cell transplant). Once perfected, the model will be used to advance new therapies for liver cancer.
这个子项目是许多利用资源的研究子项目之一
由NIH/NCRR资助的中心拨款提供。子项目的主要支持
而子项目的主要调查员可能是由其他来源提供的,
包括其它NIH来源。 列出的子项目总成本可能
代表子项目使用的中心基础设施的估计数量,
而不是由NCRR赠款提供给子项目或子项目工作人员的直接资金。
这是一个试点项目,旨在为肝癌研究和治疗创造一个新的模式。我们将创建一个狒狒肝癌模型,用于新技术,包括先进的诊断和治疗,使用复杂的成像技术来可视化和治疗肿瘤。目前还没有大型肝癌动物模型可用于开发和完善这些方法。肝癌是全球第四大癌症死亡原因。因为它是一种快速生长的肿瘤,很少在早期诊断出来,肝癌通常在诊断后一年内是致命的。在这个项目中,我们将从狒狒中克隆与肝癌相关的基因,这样所有相关的基因都与宿主同源。我们将引入基因修饰,将基因转化为癌症诱导基因或癌基因。我们将使用基因治疗载体(慢病毒载体)将多种修饰的基因导入在我们完善的狒狒肝细胞肝细胞培养系统中生长的肝细胞(肝细胞)中。首先在SCID小鼠模型中选择具有致瘤性的细胞,然后将其引入狒狒的肝脏中,狒狒是细胞的原始供体(自体细胞移植)。一旦完善,该模型将用于推进肝癌的新疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert E LANFORD其他文献
Robert E LANFORD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert E LANFORD', 18)}}的其他基金
GBV-B: A SMALL PRIMATE MODEL FOR HEPATITIS C INFECTION
GBV-B:丙型肝炎感染的小型灵长类动物模型
- 批准号:
8357644 - 财政年份:2011
- 资助金额:
$ 3.56万 - 项目类别:
NIH-Owned Chimpanzee Research Resource at the SNPRC
NIH 拥有的 SNPRC 黑猩猩研究资源
- 批准号:
8727694 - 财政年份:2011
- 资助金额:
$ 3.56万 - 项目类别:
ANALYSIS OF CHIMPANZEE PK FOR GILEAD TLR AGONIST
吉利德 TLR 激动剂在黑猩猩中的 PK 分析
- 批准号:
8357690 - 财政年份:2011
- 资助金额:
$ 3.56万 - 项目类别:
EFFICACY OF TLR7 AGONIST FOR CHRONIC HBV INFECTION IN CHIMPANZEES
TLR7 激动剂对黑猩猩慢性 HBV 感染的疗效
- 批准号:
8357720 - 财政年份:2011
- 资助金额:
$ 3.56万 - 项目类别:
CONVERSION OF IFN? NULL RESPONDER PHENOTYPE IN TO IFN RESPONDER PHENOTYPE
干扰素的转化?
- 批准号:
8357716 - 财政年份:2011
- 资助金额:
$ 3.56万 - 项目类别:
The Innate Immune Response in the Marmoset Model of GBV-B Infections: A Surrogate
GBV-B 感染狨猴模型中的先天免疫反应:替代
- 批准号:
8497598 - 财政年份:2011
- 资助金额:
$ 3.56万 - 项目类别:
The Innate Immune Response in the Marmoset Model of GBV-B Infections: A Surrogate
GBV-B 感染狨猴模型中的先天免疫反应:替代
- 批准号:
8676647 - 财政年份:2011
- 资助金额:
$ 3.56万 - 项目类别:
MOLECULAR SWITCH VACCINES FOR BIODEFENSE, CANCER, AND INFECTIOUS DISEASE
用于生物防御、癌症和传染病的分子开关疫苗
- 批准号:
8357718 - 财政年份:2011
- 资助金额:
$ 3.56万 - 项目类别:
EVALUATION OF ANTIBODY IMMUNOTHERAPY FOR HCV IN CHIMPANZEES
黑猩猩 HCV 抗体免疫治疗的评估
- 批准号:
8357719 - 财政年份:2011
- 资助金额:
$ 3.56万 - 项目类别:
NIH-Owned Chimpanzee Research Resource at the SNPRC
NIH 拥有的 SNPRC 黑猩猩研究资源
- 批准号:
8500489 - 财政年份:2011
- 资助金额:
$ 3.56万 - 项目类别:
相似海外基金
Phase I/II clinical trial of autologous T cell gene therapy to treat X-linked lymphoproliferative disease (XLP)
自体T细胞基因疗法治疗X连锁淋巴增殖性疾病(XLP)的I/II期临床试验
- 批准号:
MR/Y019458/1 - 财政年份:2024
- 资助金额:
$ 3.56万 - 项目类别:
Research Grant
Fabrication and Evaluation of Poly(glycerol sebacate) based small diameter vascular graft as a potent substitution for autologous vessels
基于聚(甘油癸二酸酯)的小直径血管移植物作为自体血管有效替代品的制造和评估
- 批准号:
2897580 - 财政年份:2023
- 资助金额:
$ 3.56万 - 项目类别:
Studentship
Autologous Bone Marrow Aspirate Concentrate for the Treatment of Osteonecrosis of the Femoral Head
自体骨髓抽吸浓缩液治疗股骨头坏死
- 批准号:
10658324 - 财政年份:2023
- 资助金额:
$ 3.56万 - 项目类别:
Identifying multimodal biomarkers for autologous serum tears in the treatment of chronic postoperative ocular pain
识别治疗慢性术后眼痛的自体血清泪液的多模式生物标志物
- 批准号:
10794761 - 财政年份:2023
- 资助金额:
$ 3.56万 - 项目类别:
SBIR Phase II: An Injectable Protein Matrix to Enhance the Stability of Autologous Fat Grafts
SBIR II 期:可注射蛋白质基质,增强自体脂肪移植物的稳定性
- 批准号:
2304430 - 财政年份:2023
- 资助金额:
$ 3.56万 - 项目类别:
Cooperative Agreement
Application of Autologous Connective Tissue Sheets Created in Patients' Bodies to Pediatric Cardiac Valvuloplasty and Development of Dedicated Molds
患者体内自体结缔组织片在小儿心脏瓣膜成形术中的应用及专用模具的开发
- 批准号:
23K15543 - 财政年份:2023
- 资助金额:
$ 3.56万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
MICA: Strategy for heart repair in Duchenne Muscular Dystrophy (DMD) using genetically engineered autologous Mesoangioblasts
MICA:利用基因工程自体中成血管细胞修复杜氏肌营养不良症 (DMD) 的心脏的策略
- 批准号:
MR/X00466X/1 - 财政年份:2023
- 资助金额:
$ 3.56万 - 项目类别:
Fellowship
Planning a phase I study of minor salivary gland derived autologous MSCs for prevention of long-term radiation induced xerostomia
计划对小唾液腺来源的自体 MSC 进行 I 期研究,以预防长期辐射引起的口干症
- 批准号:
10720234 - 财政年份:2023
- 资助金额:
$ 3.56万 - 项目类别:
SBIR PHASE II, TOPIC 429: A NEW PARADIGM FOR AUTOLOGOUS AND ALLOGENEIC CELL THERAPY MANUFACTURING
SBIR 第二阶段,主题 429:自体和同种异体细胞治疗制造的新范式
- 批准号:
10976161 - 财政年份:2023
- 资助金额:
$ 3.56万 - 项目类别:
Evaluation of a therapeutic vaccination strategy with motif neoepitope peptide-pulsed autologous dendritic cells for non-small cell lung cancer patients harboring a charged HLA-B binding pocket.
使用基序新表位肽脉冲的自体树突状细胞对携带带电 HLA-B 结合袋的非小细胞肺癌患者的治疗性疫苗接种策略进行评估。
- 批准号:
10721983 - 财政年份:2023
- 资助金额:
$ 3.56万 - 项目类别:














{{item.name}}会员




